Cervical insufficiency
Synonyms
• Cervical incompetence
Definitions
• Cervical effacement: Process of softening, shortening, and thinning of cervix in
preparation for delivery
• Cervical dilation: Progress enlargement of cervical canal to fully dilated at 10
cm
• Cervical insufficiency (CI): Inability of uterine cervix to retain pregnancy
in 2nd-trimester, in absence of uterine contractions
○ Clinical diagnosis usually based on history of midtrimester
loss without painful contractions
• Short cervix: Cervical length (CL) < 10th percentile for gestational age
(GA)
○ Sonographic observation: Length of < 25 mm at
< 24 weeks
• Funneling: Protrusion of amniotic membranes into cervical canal
• Preterm birth (PTB): Delivery before 37th week of pregnancy
General Features
• Best diagnostic clue ○ CL < 10th percentile
for GA on transvaginal ultrasound (TVUS) indicates short cervix
– < 25 mm at < 24 weeks is short
– 25 mm is 50th percentile at 32 weeks
Ultrasonographic Findings
• Dilated internal os (IO): Measure
anterior-posterior diameter
• Progressive dilation with changing shape of
IO/cervical canal from T→ Y → V → U
○ Normal membranes create T shape at IO
• Membranes may funnel through dilated cervix to
external os (EO) or beyond
• Check CL at beginning of exam as cervix is
dynamic
○ Length is shortest in patients who have recently
been upright
• Amniotic fluid "sludge" (attributed to
inflammatory debris)
Imaging Recommendations
• Best imaging tool
○ TVUS essential in high-risk patients or if CL
< 30 mm on transabdominal ultrasound (TAUS)
○ Consider transperineal ultrasound if TVUS is contraindicated
• Protocol advice
○ TVUS technique; have patient empty bladder
completely
– Carefully insert probe while watching screen,
advance until cervix clearly seen
– Find midline sagittal plane, withdraw transducer
until cervix just in focus
□ Avoids excessive vaginal transducer pressure,
which may falsely increase length
– Magnify image so cervix occupies 75% of screen
– Measure from IO to EO
□ Obtain measurements over 3-5 minutes
□ Apply fundal pressure for 15 seconds
○ Perform serial evaluation of CL from 16-24 weeks
in high-risk patients
– Prior 2nd-trimester loss, PTB (biggest risk
factor for PTB is prior history)
– Prior cervical surgery, diethylstilbestrol
exposure, müllerian duct anomaly
– Multiple gestations
DIFFERENTIAL DIAGNOSIS
Normal Cervix
• Hypoechoic cervical canal can mimic fluid in
cervical canal
Nabothian Cyst
• Can mimic fluid in cervical canal
PATHOLOGY
General Features
• CI is multifactorial (inflammation, infection,
uterine overdistention, prior trauma/surgery, loss of stromal
resistance)
○ Intrinsic weakness
○ Connective tissue disease
CLINICAL ISSUES
Presentation
• Most common signs/symptoms
○ Painless cervical dilation leading to delivery in
2ndtrimester
○ Short cervix can be incidental finding in
low-risk patient or be found during screening of high-risk patient
• Ultrasound more sensitive to cervical shortening
than manual exam at < 32 weeks
Demographics
• Short cervix seen in 1% of singleton pregnancies,
6% of twins, 20% of triplets
Natural History & Prognosis
• PTB (12% of all pregnancies in USA) is leading
cause of perinatal morbidity and mortality
○ CI is one of many causes
○ Short cervix is marker of increased risk for PTB
– CL ≤ 25 mm at 16-24 weeks associated with ↑ PTB rates
□ 18% in low risk, 55% in high risk, 60% in twins
• PTB risk increases with shorter CL, progressive
shortening
○ 0.2% risk at CL > 40 mm vs. 78% if CL = 5 mm
○ Risk increases 3% for each additional 1 mm of CL
change from 24 to 28 weeks
• Worse prognosis if short cervix + funneling
○ Funneling > 50% of CL is most significant (79%
risk PTB)
• Worse if intraamniotic inflammation or infection
(IAI)
○ Look for amniotic fluid sludge, independent risk
factor for PTB
• Qualitative fetal fibronectin (fFN) test is
positive or negative
○ + fFN result of chorion/decidua disruption
○ - fFN has high negative predictive value; ↓
unnecessary Interventions
• Ongoing research into role of quantitative fetal
fFN measurement in combination with CL measurement
Noninvasive Treatment
• Most patients at risk for CI can be safely
monitored with serial TVUS examinations
○ Duration of surveillance 16-24 weeks
– May avoid history-indicated cerclage in > 50%
if CL normal
• Evaluate patients with short cervix for preterm
labor, infection
• Progesterone administration is ongoing and active area of
investigation regarding optimal dose and route
○ Intramuscular 17-hydroxyprogesterone may be given
to women with history of prior PTB
○ Vaginal progesterone (VP) is given to women with
short cervix and no history of prior PTB
• VP as effective as cervical cerclage in reducing
PTB in women with singleton, prior PTB, short cervix
• Pessary placement has potential benefit in
high-risk patients but is not FDA approved for use in USA
• Activity restriction, bed rest, and pelvic rest
have not been proved to be effective for treatment of CI, and their use is discouraged
Cerclage
• Cervical cerclage limited to 2nd-trimester
pregnancies almost always before viability
○ Indications: Prophylactic, US indicated or rescue
○ Placement: Vaginal or abdominal
• Transvaginal cerclage suture placed as cranial as possible for longest CL, removed at
36-38 weeks
○ McDonald: Pursestring or cloverleaf configuration
○ Shirodkar technique aims for higher placement on
cervix
• Transabdominal cerclage (TAC) placed around lower uterine segment; cesarean
delivery required
○ If transvaginal cerclage not possible or prior
failure
○ TAC outcomes equivalent for open and laparoscopic
placement
• If prior PTB at < 34 weeks + CL < 15 mm,
cerclage seems to be effective for prevention of PTB
○ Cerclage not effective for prevention of PTB in
patients with short cervix and no prior PTB history
○ Interaction of cerclage and VP is unclear
• Rescue cerclage may prolong pregnancy by 4-5
weeks
○ 2x reduction in PTB prior to 34 weeks
– No large randomized trials to prove benefit, therefore,
must counsel patients about potential risks
○ Greater risk of failure when EO > 4 cm or
hourglass membranes
• Cerclage potentially harmful in multiple gestations
• Cerclage monitoring is controversial
○ American College Obstetrics and Gynecology
bulletin says not required
○ Proponents argue that it helps counsel patients regarding
prognosis if signs of stitch failure
– Membranes at or beyond level of suture
○ In women with history-indicated cerclage,
funneling is independent risk factor for PTB < 34 weeks
– Odds ratio 10.6 if membranes to stitch < 15 mm
at 18- 24 weeks
DIAGNOSTIC CHECKLIST
Consider
• TVUS is best, most reproducible technique for
evaluation of CL
• Offer nuchal translucency and 1st-trimester
screening for patients receiving early, history-indicated cerclage
Reporting Tips
• Report single best, shortest CL, widest IO,
measured on TVUS
○ Note GA, history of prior PTB
○ Note shape, depth, width of funnel (extent of
funneling)
• If scan performed for cerclage follow-up
○ Look for circumferential, echogenic sutures
○ Measure functional CL (length of closed cervix
regardless of sutures)
○ Measure length from end of funnel to suture
○ Document funneling to or beyond suture
Imaging gallery
TVUS shows the membranes (open arrow) funneling into a U-shaped, dilated cervix with functional length of 6mm (calipers) at 32 weeks. This finding confers increased risk of preterm birth (PTB).
|
In abdominal cerclage, the suture (white arrows) is in the lower uterine segment at the level of the internal os (blue arrow).
|